Accenture, today announced it has created an open partner ecosystem developed in partnership with Merck and Amazon Web Services (AWS) designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
Life Sciences Partner Ecosystem Overview
Built on Amazon Web Services and supported by ongoing work between Accenture and AWS through the Accenture AWS Business Group, the platform is designed to help life sciences organizations improve productivity, efficiency, and innovation in drug discovery.
By offering immediate access to innovative tools within a common informatics framework, the ecosystem will help life sciences companies improve productivity, efficiency, and innovation in drug discovery, saving time and expense and significantly improving patient outcomes.
Independent Software Vendors (ISVs) working with Accenture
Currently, Accenture is working with more than 30 ISVs to incorporate their technology, applications, and content into the platform, including:
– ChemAxon, a provider of highly integrable software with chemical and biological intelligence for the life sciences, flavors, cosmetics, new materials, petro– and agro-chemistry industries;
– Clarivate Analytics, a global company offering trusted insights and analytics to help companies accelerate the pace of innovation, including a comprehensive suite of solutions for life science professionals;
– Dotmatics, a company specializing in scientific informatics solutions for the management, query, and visualization of chemistry and biology data;
– SciBite, a provider of text mining, semantics and data intelligence within the biopharma and biotech industries;
– Scilligence, a company that delivers cross-platform, mobile cheminformatics and bioinformatics solutions; and
– Vyasa, a provider of scalable, deep-learning software and analytics for life sciences and healthcare organizations.
“While our life sciences clients need to be nimble in their ability to provide scientific researchers with leading technology capabilities, they are faced with legacy IT systems and complex processes that make integrating new solutions challenging,” said Brad Michel, managing director of Accenture Scientific Informatics Services. “The new ecosystem we’re creating around the Accenture research platform will offer immediate access to innovative tools, enabling life sciences companies to significantly reduce the time, expense and effort required to implement new technology solutions—accelerating drug discovery and delivering solutions to patients faster.”
